Cargando…

An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma

BACKGROUND: Nuclear accumulation of the intracellular domain of epithelial cell adhesion molecule (Ep-ICD) in tumor cells was demonstrated to predict poor prognosis in thyroid carcinoma patients in our earlier study. Here, we investigated the clinical significance of Ep-ICD subcellular localization...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Helen C.-H., Kashat, Lawrence, Kak, Ipshita, Kunavisarut, Tada, Gundelach, Raefe, Kim, Dae, So, Anthony K.-C., MacMillan, Christina, Freeman, Jeremy L., Ralhan, Ranju, Walfish, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458098/ https://www.ncbi.nlm.nih.gov/pubmed/23049733 http://dx.doi.org/10.1371/journal.pone.0042893

Ejemplares similares

Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma
por: Kunavisarut, Tada, et al.
Publicado: (2012)

Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients
por: Srivastava, Gunjan, et al.
Publicado: (2014)

Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015)

Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers
por: Ralhan, Ranju, et al.
Publicado: (2010)

EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis
por: Ralhan, Ranju, et al.
Publicado: (2010)

Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)

Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
por: Somasundaram, Raj Thani, et al.
Publicado: (2016)

Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants
por: Chowdhury, Subrata, et al.
Publicado: (2016)

Programmed Death - Ligand 1 Expression Distinguishes Invasive Encapsulated Follicular Variant of Papillary Thyroid Carcinoma from Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features
por: Fu, Guodong, et al.
Publicado: (2017)

ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016)

Programmed death-ligand 1 expression by digital image analysis advances thyroid cancer diagnosis among encapsulated follicular lesions
por: Hsieh, Anne M.-Y., et al.
Publicado: (2018)

Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy
por: Srivastava, Gunjan, et al.
Publicado: (2015)

Slug Is a Predictor of Poor Prognosis in Esophageal Squamous Cell Carcinoma Patients
por: Hasan, Md. Raghibul, et al.
Publicado: (2013)

Transglutaminase 2 Overexpression in Tumor Stroma Identifies Invasive Ductal Carcinomas of Breast at High Risk of Recurrence
por: Assi, Jasmeet, et al.
Publicado: (2013)

Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis
por: Hasan, Raghibul, et al.
Publicado: (2014)

Unilateral autoimmune inner ear disease in a patient with lung cancer treated with nivolumab
por: Rajapakse, Aleksandra, et al.
Publicado: (2020)

Clinical Significance of Altered Expression of β-Catenin and E-Cadherin in Oral Dysplasia and Cancer: Potential Link with ALCAM Expression
por: Kaur, Jatinder, et al.
Publicado: (2013)

Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015)

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer
por: Kumar, Manish, et al.
Publicado: (2015)

Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma
por: Matta, Ajay, et al.
Publicado: (2009)

Prediction of recurrence free survival for esophageal cancer patients using a protein signature based risk model
por: Hasan, Raghibul, et al.
Publicado: (2022)

ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction
por: So, Lawrence, et al.
Publicado: (2006)

Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future
por: Suwansaksri, Nattakarn, et al.
Publicado: (2018)

Beta-cell function in type 2 diabetic patients who failed to maintain good glycemic status with a combination of maximum dosages of metformin and sulfonylurea
por: Kunavisarut, Tada, et al.
Publicado: (2019)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn, Thanida, et al.
Publicado: (2021)

Benefits of Long-Term Continuation of Low-Dose Methimazole Therapy in the Prevention of Recurrent Hyperthyroidism in Graves' Hyperthyroid Patients: A Randomized Prospective Controlled Study
por: Lertwattanarak, Raweewan, et al.
Publicado: (2022)

Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
por: Chauhan, S S, et al.
Publicado: (2015)

Soluble and Membranous Vascular Endothelial Growth Factor Receptor-2 in Pregnancies Complicated by Pre-Eclampsia
por: Tripathi, Richa, et al.
Publicado: (2009)

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
por: Majumder, Mousumi, et al.
Publicado: (2018)

Nuclear S100A7 Is Associated with Poor Prognosis in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2010)

Subcutaneous ICD for more and transvenous ICD for few?!
por: Abdin, Amr, et al.
Publicado: (2022)

Efficacy of Once Daily versus Divided Daily Administration of Low Daily Dosage (15 mg/Day) of Methimazole in the Induction of Euthyroidism in Graves' Hyperthyroidism: A Randomized Controlled Study
por: Sriussadaporn, Sutin, et al.
Publicado: (2017)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

Over-expression of 14-3-3zeta is an early event in oral cancer
por: Matta, Ajay, et al.
Publicado: (2007)

Traumatic experiences, ICD‐11 PTSD, ICD‐11 complex PTSD, and the overlap with ICD‐10 diagnoses
por: Møller, L., et al.
Publicado: (2020)

14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells
por: Macha, Muzafar A, et al.
Publicado: (2010)

A Case of Patch Stage of Kaposi’s Sarcoma and Discussion of the Differential Diagnosis
por: Kak, Ipshita, et al.
Publicado: (2016)

Early life adoption shows rearing environment supersedes transgenerational effects of paternal stress on aggressive temperament in the offspring
por: Zutshi, Ipshita, et al.
Publicado: (2021)

Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2011)

Mindfulness Education for Otolaryngology Residents: A Pilot Study
por: Kashat, Lawrence, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qfoq917nf3brmi4c1kk96q0c39